OTC Deficiency With a Low PELD Score: Exception Points and a Heterozygous Mother as Donor
A 2-year-old boy with ornithine transcarbamylase deficiency has had three hyperammonemic crises in 6 months, the highest ammonia 380 µmol/L; each required ICU admission and one required hemodialysis. Between episodes he takes sodium phenylbutyrate and citrulline and follows a 1.2 g/kg/day protein-restricted diet. His ammonia is 45 µmol/L, and he has mild speech delay. Bilirubin 0.6 mg/dL, albumin 4.0 g/dL, INR 1.0, and there is no ascites or varices. His calculated PELD score is 3. His blood type is O and he is CMV IgG negative. Both parents have been evaluated: the father is ABO-compatible; the mother is a known OTC heterozygote with normal liver enzymes and ammonia. The family asks why he cannot receive exception points immediately.
1. How do you justify and structure a nonstandard MELD/PELD exception request for this child?
Read the worked answer
The request rests on risk of death or irreversible neurologic injury that the calculated PELD does not capture. PELD measures bilirubin, albumin, INR, age under 1 year, and growth failure - none of which reflect the danger of a metabolic crisis in a child with normal synthetic function.
What the review board needs:
- Confirmed diagnosis: enzyme or molecular testing documenting OTC deficiency.
- Documented crises: dates, peak ammonia levels, ICU days, dialysis, and treatments given, plus evidence that therapy was optimized (nitrogen scavengers, citrulline or arginine, protein restriction with essential amino acid supplementation, carnitine, avoidance of fasting) before the episodes occurred.
- Evidence of neurologic impact: formal neuropsychologic or developmental testing, not just a parent's impression.
- A statement of the requested score and its justification - typically a score comparable to the median score in the region for children at similar risk, with a defined review interval.
- A plan for re-review, usually every 3 months, with explicit criteria for continuation.
The family should be told plainly that exception requests take time, are not guaranteed, and that the parallel living-donor pathway may be faster. Do not promise points; promise advocacy.
2. Which parent should donate, and what are the risks of using the carrier mother?
Read the worked answer
Prefer the father unless there is an anatomic or medical reason he cannot donate.
- OTC deficiency is X-linked. The mother is heterozygous, so her liver is a mosaic of OTC-normal and OTC-deficient hepatocytes owing to lyonization. Grafts from carrier mothers have been used successfully, but the graft has reduced total enzyme capacity and there are reports of post-transplant hyperammonemia during catabolic stress such as steroid pulses, infection, or rejection.
- The father would provide a wild-type graft with full enzyme activity, removing that variable from an already complex postoperative course.
- If the mother is chosen - for example, because of better graft size or vascular anatomy - plan for closer ammonia and amino acid monitoring, minimize steroid exposure, avoid prolonged fasting, and counsel the family that a catabolic illness could unmask hyperammonemia in the graft.
Donor evaluation does not stop at genetics:
- Graft-recipient weight ratio should be roughly 2–4% for a left lateral segment.
- Assess donor steatosis, vascular and biliary anatomy, and psychosocial suitability.
- Counsel both parents about donor risk, including the small but real risk of death and the longer recovery after donor hepatectomy. Document consent separately for each parent.
3. How do you bridge him to transplant, and should transplant be preemptive or after the next crisis?
Read the worked answer
Transplant before the next crisis. Each episode carries a risk of cerebral edema, death, and cumulative cognitive injury, and the child already has speech delay.
Bridging therapy:
- Sodium phenylbutyrate 450–600 mg/kg/day divided, with citrulline or arginine supplementation; add carnitine if levels are low.
- Protein at 0.8–1.2 g/kg/day using essential amino acid formula; involve a metabolic dietitian. A gastrostomy may be needed to deliver adequate calories and protein overnight and to prevent catabolism.
- Strict sick-day rules: no fasting beyond about 6–8 hours, intravenous dextrose-containing fluids for any illness or vomiting, treat constipation, and avoid valproate and high-dose steroids.
- Teach the family to recognize early encephalopathy and to come in immediately rather than wait.
Timing:
- A child with normal synthetic function can wait years for a deceased-donor offer and may never develop cirrhosis; the MELD/PELD system was not built for this phenotype. Living-donor transplant is often the realistic path.
- Do not let the next crisis be the trigger for evaluation. Complete the transplant evaluation now, while the child is stable, so that listing and donor workup are already done.
Post-transplant: amino acid levels normalize quickly, but a partial graft plus steroid-related catabolism can produce transient hyperammonemia. Monitor ammonia and protein tolerance closely in the first weeks.